2022 SCAI SHOCK

Optimizing Antiplatelet Therapy in Cardiogenic Shock

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Participants can earn ABIM MOC points equivalent to the amount of CME credits claimed for the activity.

Acknowledgment of Commercial Support
This activity is supported by an unrestricted educational grant from Chiesi. No in-kind commercial support was received.

Case Presentation
Rhian E. Davies, DO MS, FSCAI, WellSpan Cardiology - York, York, PA
Antiplatelet Concerns and Pharmacodynamics in Cardiogenic Shock
Gregory Serrao, MD, FSCAI, Icahn School of Medicine at Mount Sinai, New York, NY
Cangrelor: Trial Data, Indications, and Contraindications
Jennifer A Rymer, MD, MBA, MHS, Duke University Hospital, Chapel Hill, NC
Case Presentation With Questions
Rhian E. Davies, DO MS, FSCAI, WellSpan Cardiology - York, York, PA
See more of: SCAI SHOCK